Overview

Comparative Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone in Perimenopausal Women

Status:
Recruiting

Trial end date:
2023-05-01

Target enrollment:

Participant gender:

Summary

To obtain new data allowing personalizing continuous hormonal therapy in perimenopausal women in Russia, the following clinical study is going to be conducted in the Russian Federation:

Phase:

Phase 4

Details

Lead Sponsor:

Scientific Research Institute of Public Health, Russian Federation

Treatments:

Dydrogesterone
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Polyestradiol phosphate